An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules
Authors:
- Giulia TomainoGiulia Tomaino
- Camilla PantaleoniCPCamilla Pantaleoni
- Annalisa D’urzoADAnnalisa D’urzo
- Carlo SantambrogioCarlo Santambrogio
- Filippo TestaFTFilippo Testa
- Matilde CiprandiMCMatilde Ciprandi
- Davide CotugnoDCDavide Cotugno
- Gianni FrascottiGFGianni Frascotti
- Marco VanoniMVMarco Vanoni
- Paolo TortoraPTPaolo Tortora
Open Access
- 16 June 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6629
Abstract
Vaults are eukaryotic ribonucleoproteins consisting of 78 copies of the major vault protein (MVP), which assemble into a nanoparticle with an about 60 nm volume-based size, enclosing other proteins and RNAs. Regardless of their physiological role(s), vaults represent ideal, natural hollow nanoparticles, which are produced by the assembly of the sole MVP. Here, we have expressed in Komagataella phaffi and purified an MVP variant carrying a C-terminal Z peptide (vault-Z), which can tightly bind an antibody’s Fc portion, in view of targeted delivery. Via surface plasmon resonance analysis, we could determine a 2.5 nM affinity to the monoclonal antibody Trastuzumab (Tz)/vault-Z 1:1 interaction. Then, we characterized the in-solution interaction via co-incubation, ultracentrifugation, and analysis of the pelleted proteins. This showed virtually irreversible binding up to an at least 10:1 Tz/vault-Z ratio. As a proof of concept, we labeled the Fc portion of Tz with a fluorophore and conjugated it with the nanoparticle, along with either Tz or Cetuximab, another monoclonal antibody. Thus, we could demonstrate antibody-dependent, selective uptake by the SKBR3 and MDA-MB 231 breast cancer cell lines. These investigations provide a novel, flexible technological platform that significantly extends vault-Z’s applications, in that it can be stably conjugated with finely adjusted amounts of antibodies as well as of other molecules, such as fluorophores, cell-targeting peptides, or drugs, using the Fc portion as a scaffold.Keywords
Funding Information
- Italian Ministry of University and Research
- CHRONOS (Chronical Multifactorial Disorders Explored by Novel Integrated Strategies)
This publication has 51 references indexed in Scilit:
- Decolorization and detoxification of synthetic dye compounds by laccase immobilized in vault nanoparticlesBioresource Technology, 2022
- Comparison of methods for quantitative biomolecular interaction analysisAnalytical and Bioanalytical Chemistry, 2021
- A comparative investigation of random and oriented immobilization of protein A ligands on the binding of immunoglobulin GBiochemical Engineering Journal, 2018
- A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptakeBiochimica et Biophysica Acta (BBA) - General Subjects, 2018
- Synthesis and assembly of human vault particles in yeastBiotechnology and Bioengineering, 2018
- Modular approach for theranostic polymer conjugates with activatable fluorescence: Impact of linker design on the stimuli-induced release of doxorubicinJournal of Controlled Release, 2018
- Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic reviewColloids and Surfaces B: Biointerfaces, 2017
- Developments and future clinical outlook of taxane nanomedicinesJournal of Controlled Release, 2017
- Nanoparticle delivery of a peptide targeting EGFR signalingJournal of Controlled Release, 2012
- Vaults and the major vault protein: Novel roles in signal pathway regulation and immunityCellular and Molecular Life Sciences, 2008